Delcath Systems, Inc.
NASDAQ:DCTHMedical - Devices
-$0.23 today
- Market cap
- $685.32M
- Beta
- 0.52
- P/E (TTM)
- 751.4
- EPS (TTM)
- $0.02
Volume 0.59M
Average 0.42M
DCTH EBITDA Margin
EBITDA as a percentage of revenue.
Delcath Systems, Inc.NASDAQ: DCTH
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -3.2%
EBITDA Margin was -3.2% in Q1 FY2026, down 10.0 pp from a year earlier. On a trailing-twelve-month basis it was 1.8%, up 1.6 pp year over year. Over 3 fiscal years it widened by 1243.6 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 8.9% for the fiscal year ending Dec 2026, up from 4.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -3.2%+2.7 pp QoQ
- Last fiscal yearDec 2025
- 4.5%+74.8 pp YoY
- LTMMar 2026
- 1.8%+1.6 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 4.5%
- Year-over-year change
- +74.8pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.5% | +74.8pp |
| FY2024 | 2024-12-31 | -70.3% | +2149.5pp |
| FY2023 | 2023-12-31 | -2219.9% | -980.8pp |
| FY2022 | 2022-12-31 | -1239.1% | -555.1pp |
| FY2021 | 2021-12-31 | -684.0% | — |
EBITDA Margin vs competitors
How DCTH compares with its peers on the latest reported figures
- DCTH's LTM Mar 2026 EBITDA Margin of 1.8% is the highest of the 4 companies compared; the peer median is -46.7%.
- Its year-over-year change of +1.6 pp is the 2nd highest of 4, against a peer median of -10.7 pp.
- Over three fiscal years its change of +1243.6 pp compares with a peer median of -5.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 1.8% | +1.6 pp | +1243.6 pp | |
| LTM Mar 2026 | -23.0% | -10.7 pp | -5.5 pp | |
| LTM Mar 2026 | -46.7% | +22.3 pp | +304.0 pp | |
| LTM Mar 2026 | -17902.8% | -12192.4 pp | -11194.0 pp | |
| Peer median (excluding DCTH) | -46.7% | -10.7 pp | -5.5 pp | |
Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.56M | 2.72M | 2.07M | 37.21M | 85.23M |
| Cost of Revenue | 671K | 686K | 635K | 6.19M | 11.8M |
| Gross Profit | 2.88M | 2.03M | 1.43M | 31.02M | 73.43M |
| Gross Margin | 81.1% | 74.8% | 69.2% | 83.4% | 86.2% |
| Research & Development | 13.78M | 18.58M | 17.5M | 13.87M | 29.25M |
| Selling, General & Admin | 13.64M | 17.3M | 22.11M | 29.55M | 43.53M |
| Operating Expenses | 27.42M | 35.89M | 39.61M | 43.43M | 72.77M |
| Depreciation & Amortization | 146K | 132K | 399K | 229K | 349K |
| EBITDA | (24.32M) | (33.69M) | (45.84M) | (26.16M) | 3.86M |
| EBITDA Margin | -684.0% | -1239.1% | -2219.9% | -70.3% | 4.5% |
| Operating Income | (24.53M) | (33.85M) | (38.18M) | (12.41M) | 660K |
| Operating Margin | -690.0% | -1245.1% | -1849.0% | -33.4% | 0.8% |
| Interest Income | 0 | 0 | 0 | 125K | 2.92M |
| Interest Expense | 1.19M | 2.69M | 1.44M | 0 | 0 |
| Other Income / Expenses | (1.12M) | (2.66M) | (9.5M) | (13.98M) | 2.85M |
| Income Before Tax | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 3.51M |
| Pre-Tax Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 4.1% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 810K |
| Net Income | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 2.7M |
| Net Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 3.2% |
| EPS (Basic) | (3.59) | (4.12) | (2.94) | (0.93) | 0.08 |
| EPS (Diluted) | (3.59) | (4.12) | (2.94) | (0.93) | 0.07 |
| Weighted Avg Shares | 7.15M | 8.86M | 16.23M | 28.51M | 35.82M |
| Weighted Avg Shares (Diluted) | 7.15M | 8.86M | 16.23M | 28.51M | 39.92M |
Delcath Systems, Inc.
NASDAQ:DCTH
Intrinsic Alpha fair value
Locked
Current Price
$19.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.